Aksigen Ivf Private Limited - Company Profile

It is a business services private limited company based in Mumbai, Maharashtra, India, established in 2024.
2024 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Aksigen Ivf Private Limited

Aksigen Ivf Private Limited, a active private limited company, was established on 23 December 2024 in Mumbai, Maharashtra, India. it holds CIN: U86100MH2024PTC436915. Registered under ROC Roc Mumbai I. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹2.50 M.

Its leadership includes Karan Gautam Daftary (Director), Siddharth Bharat Daftary (Director), Gautam Vinod Daftary (Director). Past directors included Akshay Gautam Daftary. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 16Th Floor, Hoechst House, Mumbai, Maharashtra, 400021.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U86100MH2024PTC436915

  • Registration Number

    436915

  • Incorporation Date

    23 December 2024

  • Authorized Capital

    ₹2.50 M

  • Paid-Up Capital

    ₹2.50 M

  • ROC Code

    Roc Mumbai I

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.50 M
  • Paid Up Capital ₹ 2.50 M
  • Company Age 1 Year 2 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Aksigen Ivf Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Aksigen Ivf Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Aksigen Ivf Private Limited?
Current Directors
Name Designation Appointment Date Status
Karan Gautam Daftary Director 23 Dec 2024 Current
Siddharth Bharat Daftary Director 23 Dec 2024 Current
Gautam Vinod Daftary Director 23 Dec 2024 Current
Akshay Gautam Daftary Additional Director 19 Sep 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Individual Subscriber - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Aksigen Ivf.
Aksigen Ivf revenue growth over time
Aksigen Ivf profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Aksigen Ivf?

Unlock access to Aksigen Ivf's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Aksigen Ivf?

Unlock and access historical data on people associated with Aksigen Ivf, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Aksigen Ivf, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aksigen Ivf's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Aksigen Ivf
Recent Activity within the Organization
  • Annual General Meeting

    The activity Aksigen Ivf Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Director Appointment

    Progress on Akshay Gautam Daftary was appointed as a Additional Director was appointed as a Additional Director on 19 Sep 2025 & has been associated with this company since 5 months 11 days . was documented.

  • Balance Sheet

    Progress on Aksigen Ivf Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I. was documented.

  • Director Appointment

    Karan Gautam Daftary was appointed as a Director was appointed as a Director on 23 Dec 2024 & has been associated with this company since 1 year 2 months . was recorded as a recent event.

  • Director Appointment

    Progress on Siddharth Bharat Daftary was appointed as a Director was appointed as a Director on 23 Dec 2024 & has been associated with this company since 1 year 2 months . was documented.

  • Director Appointment

    Gautam Vinod Daftary was appointed as a Director was appointed as a Director on 23 Dec 2024 & has been associated with this company since 1 year 2 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Aksigen Ivf Private Limited?

The CIN of Aksigen Ivf Private Limited is U86100MH2024PTC436915.

Where is Aksigen Ivf Private Limited headquartered?

Aksigen Ivf Private Limited is headquartered at 16Th Floor, Hoechst House, Mumbai, Maharashtra, 400021.

When was Aksigen Ivf Private Limited incorporated?

Aksigen Ivf Private Limited was incorporated on 23 December 2024.

Who are the current directors of Aksigen Ivf Private Limited?

The current directors of Aksigen Ivf Private Limited are

Is Aksigen Ivf Private Limited a listed company?

Aksigen Ivf Private Limited is unlisted.

What is the capital structure of Aksigen Ivf Private Limited?

The authorized capital of Aksigen Ivf Private Limited is ₹2.50 M, and the paid-up capital is ₹2.50 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available